Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Marta, Miarons"'
Autor:
Sonia Luque, Natalia Mendoza-Palomar, David Aguilera-Alonso, Beatriz Garrido, Marta Miarons, Ana Isabel Piqueras, Enrique Tévar, Eneritz Velasco-Arnaiz, Aurora Fernàndez-Polo
Publikováno v:
Anales de Pediatría (English Edition), Vol 101, Iss 3, Pp 190-207 (2024)
Therapeutic monitoring of antibiotics and antifungals based on pharmacokinetic and pharmacodynamic (PK/PD) parameters is a strategy increasingly used for the optimization of therapy to improve efficacy, reduce the occurrence of toxicities, and preven
Externí odkaz:
https://doaj.org/article/fb16add2c6164fe18c6b433256bdc0d2
Autor:
Betina Biagetti, Adrián Sánchez-Montalvá, Albert Puig-Perez, Isabel Campos-Varela, María Florencia Pilia, Emilie Anderssen-Nordahl, Didac González-Sans, Marta Miarons, Rafael Simó
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Hyponatremia on admission has been related to worse outcomes in patients with COVID-19 infection. However, little is known about the frequency and the associated risk factors of hyponatremia after COVID-19 discharge. We performed an observat
Externí odkaz:
https://doaj.org/article/fed4fea0fb2542a3964d7222d8406e8a
Autor:
Adrián Sánchez-Montalvá, Daniel Álvarez-Sierra, Mónica Martínez-Gallo, Janire Perurena-Prieto, Iria Arrese-Muñoz, Juan Carlos Ruiz-Rodríguez, Juan Espinosa-Pereiro, Pau Bosch-Nicolau, Xavier Martínez-Gómez, Andrés Antón, Ferran Martínez-Valle, Mar Riveiro-Barciela, Albert Blanco-Grau, Francisco Rodríguez-Frias, Pol Castellano-Escuder, Elisabet Poyatos-Canton, Jordi Bas-Minguet, Eva Martínez-Cáceres, Alex Sánchez-Pla, Coral Zurera-Egea, Aina Teniente-Serra, Manuel Hernández-González, Ricardo Pujol-Borrell, the “Hospital Vall d’Hebron Group for the study of COVID-19 immune profile”, Artur Llobell Uriel, Romina Dieli, Roger Colobran, Gemma Codina, Tomas Pumarola, Roser Ferrer, Vicente Cortina, Magda Campins, Isabel Ruiz, Nuria Fernaíndez, Esteban Ribera, Joan Roig, Ricardo Ferrer, Adolfo Ruiz-Sanmartín, Albert Selva, Moises Labrador, María José Soler Romeo, Jaume Ferrer, Eva Polverino, Antonio Alvarez, María Queralt Gorgas, Marta Miarons, Pere Soler-Palacin, Andrea Martin, Anna Suy, Maria Jose Buzón, Meritxell Genescà, Santiago Perez-Hoyos, Miriam Mota-Foix
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundTwo years since the onset of the COVID-19 pandemic no predictive algorithm has been generally adopted for clinical management and in most algorithms the contribution of laboratory variables is limited.ObjectivesTo measure the predictive per
Externí odkaz:
https://doaj.org/article/63c95253f23f4a5e9435299532447b15
Autor:
Cristina Aguilera, Immaculada Danés, Elena Guillén, Alba Vimes, Montserrat Bosch, Gloria Cereza, Adrián Sánchez-Montalvá, Isabel Campos-Varela, Marta Miarons, Jaume Mestre-Torres, Antònia Agustí
Publikováno v:
Diagnostics, Vol 12, Iss 7, p 1612 (2022)
The emergency of the coronavirus disease 2019 (COVID-19) pandemic led to the off-label use of drugs without data on their toxicity profiles in patients with COVID-19, or on their concomitant use. Patients included in the COVID-19 Patient Registry of
Externí odkaz:
https://doaj.org/article/0f1f118e37c94f6cbcffa3582afe845d
Autor:
Cristina Andrés, Alejandra González-Sánchez, Moraima Jiménez, Ester Márquez-Algaba, Maria Piñana, Candela Fernández-Naval, Juliana Esperalba, Narcís Saubi, Josep Quer, Ariadna Rando-Segura, Marta Miarons, Maria Gema Codina, Isabel Ruiz-Camps, Tomàs Pumarola, Pau Abrisqueta, Andrés Antón
Publikováno v:
Clinical Microbiology and Infection. 29:240-246
To monitor the early emergence of genetic mutations related to reduced susceptibility to monoclonal anti-body (mAb)-based treatment in immunocompromised patients with long-term viral excretion using whole-genome sequencing at a tertiary university ho
Autor:
Yolanda Villena-Ortiz, Laura Castellote-Bellés, Luisa Martinez-Sanchez, María I. Benítez-Carabante, Marta Miarons, Jaume Vima-Bofarull, Raquel Barquin-DelPino, Rosanna Paciucci, Francisco Rodríguez-Frías, Roser Ferrer-Costa, Ernesto Casis, Joan López-Hellín
Publikováno v:
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio. 3:272-281
Resumen Objetivos La administración de busulfán es ampliamente utilizada como parte del régimen de acondicionamiento en pacientes que se van a someter a trasplante de células madre hematopoyéticas. Se recomienda monitorizar las concentraciones p
Autor:
Panagiotis Nikolaos Lalagkas, Jorge Iliou, Raul Rigo, Marta Miarons, Beatriz Fernández-Alarcon, Oriol Bestard, Josep M. Cruzado, Edoardo Melilli, Joan Torras, Josep M. Grinyó, Nuria Lloberas, Helena Colom
Publikováno v:
Clinical Pharmacokinetics.
Autor:
Yolanda Villena-Ortiz, Laura Castellote-Bellés, Luisa Martinez-Sanchez, María I. Benítez-Carabante, Marta Miarons, Jaume Vima-Bofarull, Raquel Barquin-DelPino, Rosanna Paciucci, Francisco Rodríguez-Frías, Roser Ferrer-Costa, Ernesto Casis, Joan López-Hellín
Publikováno v:
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio. 3:263-271
Objectives Administration of busulfan is extending rapidly as a part of a conditioning regimen in patients undergoing hematopoietic stem cell transplantation (HSCT). Monitoring blood plasma levels of busulfan is recommended for identifying the optima
Autor:
Nuria Fernández-Hidalgo, Arnau Monforte-Pallarés, Fernando Salvador, Simeón Eremiev-Eremiev, Marta Miarons, Benito Almirante, Santiago Pérez-Hoyos, Júlia Sellarès-Nadal, Adrián Sánchez-Montalvá, Xavier Durà, Salvador Augustin, Júlia Sampol, Juan Espinosa-Pereiro, Alfredo Guillén-Del-Castillo, Abiu Sempere-González, Andrés Antón, Pau Bosch-Nicolau
Publikováno v:
Medicina Clinica
Modulation of the immune system to prevent lung injury is being widely used against the new coronavirus disease (COVID-19). The primary endpoint was mortality at 7 days after tocilizumab administration. Secondary endpoints were admission to the inten
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 46(4)
The purpose of this systematic review is to analyze the published data on the efficacy and safety of doses higher than 180 mg/m2 of irinotecan recommended in the drug's summary of product characteristics in metastatic colorectal cancer patients with